What are the major opportunities in the Subcutaneous Immunoglobulin (SCIG) market? What are the strategies for the Subcutaneous Immunoglobulin (SCIG) market?

For detailed insights on the major opportunities and strategies in the Subcutaneous Immunoglobulin (SCIG) market, Read More

How does the Subcutaneous Immunoglobulin (SCIG) market relate to the overall economy and other similar markets?

For detailed insights on Subcutaneous Immunoglobulin (SCIG)'s relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Subcutaneous Immunoglobulin (SCIG) market growth? SWOT analysis of the Subcutaneous Immunoglobulin (SCIG) market.

For detailed insights on the key dynamics influencing the Subcutaneous Immunoglobulin (SCIG) market growth and SWOT analysis of the Subcutaneous Immunoglobulin (SCIG) industry, Read More

Subcutaneous Immunoglobulin (SCIG) Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Subcutaneous Immunoglobulin (SCIG) Market Report 2026

Name: Subcutaneous Immunoglobulin (SCIG) Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product Type (Immunoglobulin A (IgA), Immunoglobulin G (IgG)), By Application (Primary Immunodeficiency Disorders, Autoimmune Diseases, Neurological Disorders, Other Applications), By End-Use (Clinics, Hospitals, Homecare, Other End-Uses) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Subcutaneous Immunoglobulin (SCIG) Market Overview

• Subcutaneous Immunoglobulin (SCIG) market size has reached to $14.39 billion in 2025

• Expected to grow to $25.71 billion in 2030 at a compound annual growth rate (CAGR) of 12%

• Growth Driver: Impact Of Secondary Immunodeficiency Diseases On The Subcutaneous Immunoglobulin Market

• Market Trend: Advancements In Subcutaneous Immunoglobulin (SCIG) Technology Improve Treatment Convenience And Patient Self-Management

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Subcutaneous Immunoglobulin (SCIG) Market?

Subcutaneous immunoglobulin (SCIG) refers to a method of administering immunoglobulin therapy in which the medication is delivered under the skin, rather than into a vein. This method allows for slower absorption of the medication, reducing the risk of side effects compared to intravenous administration. SCIG is used to treat various immune deficiencies, providing a convenient and effective way to boost the immune system.

The main types of subcutaneous immunoglobulin (SCIG) products include immunoglobulin A (IgA), immunoglobulin G (IgG), and immunoglobulin M (IgM). IgA is a type of antibody that plays a crucial role in immune defense at mucosal surfaces. It helps prevent pathogens from entering the body through mucosal membranes. They are used for several applications, such as primary immunodeficiency disorders, autoimmune diseases, neurological disorders, and others used by various end-users, including clinics, hospitals, homecare, and others.

Subcutaneous Immunoglobulin (SCIG) Market Global Report 2026 Market Report bar graph

What Is The Subcutaneous Immunoglobulin (SCIG) Market Size and Share 2026?

The subcutaneous immunoglobulin (scig) market size has grown rapidly in recent years. It will grow from $14.39 billion in 2025 to $16.32 billion in 2026 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to rising diagnosis of primary immunodeficiency disorders, limitations of intravenous immunoglobulin therapy, increasing need for long-term immune support, improved safety profile of scig, growing patient preference for at-home care.

What Is The Subcutaneous Immunoglobulin (SCIG) Market Growth Forecast?

The subcutaneous immunoglobulin (scig) market size is expected to see rapid growth in the next few years. It will grow to $25.71 billion in 2030 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to expansion of scig indications beyond immunodeficiency, increasing healthcare focus on homecare therapies, technological advancements in infusion devices, growing prevalence of autoimmune and neurological disorders, rising demand for patient-centric treatment models. Major trends in the forecast period include growing shift from ivig to scig therapies, rising adoption of home-based immunoglobulin treatment, increasing preference for self-administration devices, expansion of scig use in chronic immune disorders, higher demand for long-term immune replacement therapy.

Book your 30 minutes free consultation with our research experts

Global Subcutaneous Immunoglobulin (SCIG) Market Segmentation

1) By Product Type: Immunoglobulin A (IgA), Immunoglobulin G (IgG)

2) By Application: Primary Immunodeficiency Disorders, Autoimmune Diseases, Neurological Disorders, Other Applications

3) By End-Use: Clinics, Hospitals, Homecare, Other End-Uses

Subsegments:

1) By Immunoglobulin A (IgA): IgA1, IgA2

2) By Immunoglobulin G (IgG): IgG1, IgG2, IgG3, IgG4

What Are The Drivers Of The Subcutaneous Immunoglobulin (SCIG) Market?

The increase in the prevalence of secondary immunodeficiency diseases is expected to propel the growth of the subcutaneous immunoglobulin market going forward. Secondary immunodeficiency diseases are conditions with a reduced or compromised immune system caused by sources other than the immune system itself. The prevalence of secondary immunodeficiency diseases is driven by various factors such as aging populations, the use of immunosuppressive treatments, and environmental toxins. Subcutaneous immunoglobulin therapy provides antibodies to help strengthen the weakened immune system, especially in chronic disorders such as HIV or autoimmune diseases, thereby preventing infections and supporting immunological function during treatment. For instance, in October 2024 accroding to the HIV i-Base is a UK-based treatment activist organization in 2023, new HIV diagnoses increased by 36% among heterosexual men, rising from 445 in 2022 to 605, and by 30% among heterosexual women, rising from 602 in 2022 to 780. Therefore, the increase in the prevalence of secondary immunodeficiency diseases is driving the growth of the subcutaneous immunoglobulin market.

The increasing number of neurological disorders is expected to propel the growth of the subcutaneous immunoglobulin market going forward. A neurological disorder is any disorder of the nervous system that includes anatomical, biochemical, or electrical abnormalities in the brain, spinal cord, or peripheral nerves such as acute spinal cord injury, alzheimer's dementia, amyotrophic lateral sclerosis (ALS), ataxia, brain tumors, and others. Neurological disorders are increasing due to various factors such as aging populations, environmental toxins, genetic predispositions, and lifestyle changes. Subcutaneous immunoglobulin therapy can be beneficial in neurological disorders by providing antibodies that modulate the immune response, reduce inflammation, and stabilize neuromuscular junctions, potentially slowing disease progression and improving symptoms. For instance, in March 2023, according to the Alzheimer's Association, a US-based nonprofit voluntary health organization, 6.7 million Americans aged 65 and older are living with Alzheimer's dementia, with projections indicating this could rise to 13.8 million by 2060. Therefore, the increasing number of neurological disorders is driving the growth of the subcutaneous immunoglobulin market.

Key Players In The Global Subcutaneous Immunoglobulin (SCIG) Market

Major companies operating in the subcutaneous immunoglobulin (scig) market are CSL Behring, Grifols S.A., Octapharma AG, Kedrion Biopharma, LFB Group, Biotest AG, Bio Products Laboratory Ltd., ADMA Biologics Inc., Kamada Pharmaceuticals, Takeda Pharmaceutical Company Limited, Baxter International Inc., Bharat Serums and Vaccines Limited, Emergent BioSolutions Inc., Pfizer Inc., Johnson & Johnson, Lonza Group, Argenx SE, CinnaGen Co., Intas Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd.

Global Subcutaneous Immunoglobulin (SCIG) Market Trends and Insights

Major companies operating in the subcutaneous immunoglobulin (SCIG) market are focusing on developing advanced solutions, such as ready-to-use prefilled formulations, to enhance treatment convenience, support self-administration, and improve the overall patient experience. Ready-to-use SCIG formulations refer to premeasured, stable immunoglobulin products designed for subcutaneous delivery, allowing patients with primary immunodeficiency and other immune disorders to administer therapy more easily outside clinical settings. For instance, in April 2023, the U.S. Food and Drug Administration (FDA) approved a 50 mL / 10 g prefilled syringe presentation of Hizentra (Immune Globulin Subcutaneous [Human] 20%), providing patients with a simplified, ready-to-use option that supports more convenient home infusion and enhances treatment adherence.

Need data on a specific region in this market?

Request Regional Data

Regional Insights

North America was the largest region in the subcutaneous immunoglobulin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Subcutaneous Immunoglobulin (SCIG) Market?

The subcutaneous immunoglobulin (SCIG) market consists of revenues earned by entities by providing services such as immune system support, home-based therapy, infection prevention, personalized dosing, patient training, and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The subcutaneous immunoglobulin market also includes sales of infusion pumps, needles and catheters, syringes, and sharps disposal containers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Subcutaneous Immunoglobulin (SCIG) Market Report 2026?

The subcutaneous immunoglobulin (scig) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the subcutaneous immunoglobulin (scig) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Subcutaneous Immunoglobulin (SCIG) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$16.32 billion
Revenue Forecast In 2035	$25.71 billion
Growth Rate	CAGR of 13.4% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product Type, Application, End-Use
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	CSL Behring, Grifols S.A., Octapharma AG, Kedrion Biopharma, LFB Group, Biotest AG, Bio Products Laboratory Ltd., ADMA Biologics Inc., Kamada Pharmaceuticals, Takeda Pharmaceutical Company Limited, Baxter International Inc., Bharat Serums and Vaccines Li
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Subcutaneous Immunoglobulin (SCIG) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Subcutaneous Immunoglobulin (SCIG) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Subcutaneous Immunoglobulin (SCIG) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Growing Shift From IVIG To SCIG Therapies

4.2.2 Rising Adoption Of Home-Based Immunoglobulin Treatment

4.2.3 Increasing Preference For Self-Administration Devices

4.2.4 Expansion Of SCIG Use In Chronic Immune Disorders

4.2.5 Higher Demand For Long-Term Immune Replacement Therapy

5. Subcutaneous Immunoglobulin (SCIG) Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Homecare Settings

5.4 Immunology Centers

5.5 Neurology Clinics

6. Subcutaneous Immunoglobulin (SCIG) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Subcutaneous Immunoglobulin (SCIG) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Subcutaneous Immunoglobulin (SCIG) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Subcutaneous Immunoglobulin (SCIG) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Subcutaneous Immunoglobulin (SCIG) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Subcutaneous Immunoglobulin (SCIG) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Subcutaneous Immunoglobulin (SCIG) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Subcutaneous Immunoglobulin (SCIG) Market Segmentation

9.1. Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immunoglobulin A (IgA), Immunoglobulin G (IgG)

9.2. Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Primary Immunodeficiency Disorders, Autoimmune Diseases, Neurological Disorders, Other Applications

9.3. Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clinics, Hospitals, Homecare, Other End-Uses

9.4. Global Subcutaneous Immunoglobulin (SCIG) Market, Sub-Segmentation Of Immunoglobulin A (IgA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

IgA1, IgA2

9.5. Global Subcutaneous Immunoglobulin (SCIG) Market, Sub-Segmentation Of Immunoglobulin G (IgG), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

IgG1, IgG2, IgG3, IgG4

10. Subcutaneous Immunoglobulin (SCIG) Market Regional And Country Analysis

10.1. Global Subcutaneous Immunoglobulin (SCIG) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Subcutaneous Immunoglobulin (SCIG) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Subcutaneous Immunoglobulin (SCIG) Market

11.1. Asia-Pacific Subcutaneous Immunoglobulin (SCIG) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Subcutaneous Immunoglobulin (SCIG) Market

12.1. China Subcutaneous Immunoglobulin (SCIG) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Subcutaneous Immunoglobulin (SCIG) Market

13.1. India Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Subcutaneous Immunoglobulin (SCIG) Market

14.1. Japan Subcutaneous Immunoglobulin (SCIG) Market Overview

14.2. Japan Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Subcutaneous Immunoglobulin (SCIG) Market

15.1. Australia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Subcutaneous Immunoglobulin (SCIG) Market

16.1. Indonesia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Subcutaneous Immunoglobulin (SCIG) Market

17.1. South Korea Subcutaneous Immunoglobulin (SCIG) Market Overview

17.2. South Korea Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Subcutaneous Immunoglobulin (SCIG) Market

18.1. Taiwan Subcutaneous Immunoglobulin (SCIG) Market Overview

18.2. Taiwan Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Subcutaneous Immunoglobulin (SCIG) Market

19.1. South East Asia Subcutaneous Immunoglobulin (SCIG) Market Overview

19.2. South East Asia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Subcutaneous Immunoglobulin (SCIG) Market

20.1. Western Europe Subcutaneous Immunoglobulin (SCIG) Market Overview

20.2. Western Europe Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Subcutaneous Immunoglobulin (SCIG) Market

21.1. UK Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Subcutaneous Immunoglobulin (SCIG) Market

22.1. Germany Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Subcutaneous Immunoglobulin (SCIG) Market

23.1. France Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Subcutaneous Immunoglobulin (SCIG) Market

24.1. Italy Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Subcutaneous Immunoglobulin (SCIG) Market

25.1. Spain Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Subcutaneous Immunoglobulin (SCIG) Market

26.1. Eastern Europe Subcutaneous Immunoglobulin (SCIG) Market Overview

26.2. Eastern Europe Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Subcutaneous Immunoglobulin (SCIG) Market

27.1. Russia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Subcutaneous Immunoglobulin (SCIG) Market

28.1. North America Subcutaneous Immunoglobulin (SCIG) Market Overview

28.2. North America Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Subcutaneous Immunoglobulin (SCIG) Market

29.1. USA Subcutaneous Immunoglobulin (SCIG) Market Overview

29.2. USA Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Subcutaneous Immunoglobulin (SCIG) Market

30.1. Canada Subcutaneous Immunoglobulin (SCIG) Market Overview

30.2. Canada Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Subcutaneous Immunoglobulin (SCIG) Market

31.1. South America Subcutaneous Immunoglobulin (SCIG) Market Overview

31.2. South America Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Subcutaneous Immunoglobulin (SCIG) Market

32.1. Brazil Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Subcutaneous Immunoglobulin (SCIG) Market

33.1. Middle East Subcutaneous Immunoglobulin (SCIG) Market Overview

33.2. Middle East Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Subcutaneous Immunoglobulin (SCIG) Market

34.1. Africa Subcutaneous Immunoglobulin (SCIG) Market Overview

34.2. Africa Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Subcutaneous Immunoglobulin (SCIG) Market Regulatory and Investment Landscape

36. Subcutaneous Immunoglobulin (SCIG) Market Competitive Landscape And Company Profiles

36.1. Subcutaneous Immunoglobulin (SCIG) Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Subcutaneous Immunoglobulin (SCIG) Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Subcutaneous Immunoglobulin (SCIG) Market Company Profiles

36.3.1. CSL Behring Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Octapharma AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Kedrion Biopharma Overview, Products and Services, Strategy and Financial Analysis

36.3.5. LFB Group Overview, Products and Services, Strategy and Financial Analysis

37. Subcutaneous Immunoglobulin (SCIG) Market Other Major And Innovative Companies

Biotest AG, Bio Products Laboratory Ltd., ADMA Biologics Inc., Kamada Pharmaceuticals, Takeda Pharmaceutical Company Limited, Baxter International Inc., Bharat Serums and Vaccines Limited, Emergent BioSolutions Inc., Pfizer Inc., Johnson & Johnson, Lonza Group, Argenx SE, CinnaGen Co., Intas Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd.

38. Global Subcutaneous Immunoglobulin (SCIG) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Subcutaneous Immunoglobulin (SCIG) Market

40. Subcutaneous Immunoglobulin (SCIG) Market High Potential Countries, Segments and Strategies

40.1 Subcutaneous Immunoglobulin (SCIG) Market In 2030 - Countries Offering Most New Opportunities

40.2 Subcutaneous Immunoglobulin (SCIG) Market In 2030 - Segments Offering Most New Opportunities

40.3 Subcutaneous Immunoglobulin (SCIG) Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Subcutaneous Immunoglobulin (SCIG) Market, Overview Of Key Products - Product Examples

Table 2: Global Subcutaneous Immunoglobulin (SCIG) Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Subcutaneous Immunoglobulin (SCIG) Market, Supply Chain Analysis

Table 4: Global Subcutaneous Immunoglobulin (SCIG) Market, Major Raw Material Providers

Table 5: Global Subcutaneous Immunoglobulin (SCIG) Market, Major Resource Providers

Table 6: Global Subcutaneous Immunoglobulin (SCIG) Market, Major Manufacturers (Suppliers)

Table 7: Global Subcutaneous Immunoglobulin (SCIG) Market, Major Distributors And Channel Partners

Table 8: Global Subcutaneous Immunoglobulin (SCIG) Market, Key Technologies & Future Trends

Table 9: Global Subcutaneous Immunoglobulin (SCIG) Market, Major Trends

Table 10: Global Subcutaneous Immunoglobulin (SCIG) Market, Major End Users

Table 11: Global Subcutaneous Immunoglobulin (SCIG) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Subcutaneous Immunoglobulin (SCIG) Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Subcutaneous Immunoglobulin (SCIG) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Subcutaneous Immunoglobulin (SCIG) Market - TAM, US$ Billion, 2025

Table 15: Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Subcutaneous Immunoglobulin (SCIG) Market, Sub-Segmentation Of Immunoglobulin A (IgA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Subcutaneous Immunoglobulin (SCIG) Market, Sub-Segmentation Of Immunoglobulin G (IgG), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Subcutaneous Immunoglobulin (SCIG) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Subcutaneous Immunoglobulin (SCIG) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Indonesia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: South Korea, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Taiwan, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South East Asia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Western Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: UK, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Germany, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: France, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Italy, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Spain, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Eastern Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Russia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: North America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: USA, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: Canada, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: South America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Brazil, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Middle East, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Africa, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Global Subcutaneous Immunoglobulin (SCIG) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 95: Global Subcutaneous Immunoglobulin (SCIG) Market - Company Scoring Matrix

Table 96: CSL Behring Financial Performance

Table 97: Grifols S.A. Financial Performance

Table 98: Octapharma AG Financial Performance

Table 99: Kedrion Biopharma Financial Performance

Table 100: LFB Group Financial Performance

Table 101: Global Subcutaneous Immunoglobulin (SCIG) Market, Competitive Benchmarking (In USD Billions)

Table 102: Global Subcutaneous Immunoglobulin (SCIG) Market, Competitive Dashboard

Table 103: Global Subcutaneous Immunoglobulin (SCIG) Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 104: Global, Subcutaneous Immunoglobulin (SCIG) Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Table 105: Global, Subcutaneous Immunoglobulin (SCIG) Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Table 106: Global, Subcutaneous Immunoglobulin (SCIG) Market Size Gain ($ Billion), Segmentation By End-Use, 2025 – 2030

List Of Figures

Figure 1: Global Subcutaneous Immunoglobulin (SCIG) Market, Overview Of Key Products - Product Examples

Figure 2: Global Subcutaneous Immunoglobulin (SCIG) Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Subcutaneous Immunoglobulin (SCIG) Market, Supply Chain Analysis

Figure 4: Global Subcutaneous Immunoglobulin (SCIG) Market, Major Raw Material Providers

Figure 5: Global Subcutaneous Immunoglobulin (SCIG) Market, Major Resource Providers

Figure 6: Global Subcutaneous Immunoglobulin (SCIG) Market, Major Manufacturers (Suppliers)

Figure 7: Global Subcutaneous Immunoglobulin (SCIG) Market, Major Distributors And Channel Partners

Figure 8: Global Subcutaneous Immunoglobulin (SCIG) Market, Key Technologies & Future Trends

Figure 9: Global Subcutaneous Immunoglobulin (SCIG) Market, Major Trends

Figure 10: Global Subcutaneous Immunoglobulin (SCIG) Market, Major End Users

Figure 11: Global Subcutaneous Immunoglobulin (SCIG) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Subcutaneous Immunoglobulin (SCIG) Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Subcutaneous Immunoglobulin (SCIG) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Subcutaneous Immunoglobulin (SCIG) Market - TAM, US$ Billion, 2025

Figure 15: Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Subcutaneous Immunoglobulin (SCIG) Market, Sub-Segmentation Of Immunoglobulin A (IgA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Subcutaneous Immunoglobulin (SCIG) Market, Sub-Segmentation Of Immunoglobulin G (IgG), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Subcutaneous Immunoglobulin (SCIG) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Subcutaneous Immunoglobulin (SCIG) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Indonesia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: South Korea, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Taiwan, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South East Asia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Western Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: UK, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Germany, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: France, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Italy, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Spain, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Eastern Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Russia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: North America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: USA, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: Canada, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: South America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Brazil, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Middle East, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Africa, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Global Subcutaneous Immunoglobulin (SCIG) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 95: Global Subcutaneous Immunoglobulin (SCIG) Market - Company Scoring Matrix

Figure 96: CSL Behring Financial Performance

Figure 97: Grifols S.A. Financial Performance

Figure 98: Octapharma AG Financial Performance

Figure 99: Kedrion Biopharma Financial Performance

Figure 100: LFB Group Financial Performance

Figure 101: Global Subcutaneous Immunoglobulin (SCIG) Market, Competitive Benchmarking (In USD Billions)

Figure 102: Global Subcutaneous Immunoglobulin (SCIG) Market, Competitive Dashboard

Figure 103: Global Subcutaneous Immunoglobulin (SCIG) Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 104: Global, Subcutaneous Immunoglobulin (SCIG) Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Figure 105: Global, Subcutaneous Immunoglobulin (SCIG) Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Figure 106: Global, Subcutaneous Immunoglobulin (SCIG) Market Size Gain ($ Billion), Segmentation By End-Use, 2025 – 2030

Oral Transmucosal Drugs Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Oral Transmucosal Drugs Market Landscape: Innovative Preservative-Free Lubricant Eye Drops For Rapid Relief And Lasting Hydration

Top Trends Driving Innovation and Change in the Over The Counter (OTC) Drugs Market: Advancements In Over-The-Counter Nasal Sprays Transforming The Over-The-Counter Drug Market

Market Trends Influencing Strategic Decisions in the Oxycodone Drugs Industry: Focus On Developing Immediate-Release Tablets To Combat Drug Abuse In Oxycodone Drug Market

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Immunoglobulins Market Report 2026 - Global Outlook – By Product (IGG, IGA, IGM, IGE, IGD), By Mode Of Delivery (Intravenous Mode Of Delivery, Subcutaneous Mode Of Delivery ), By Application (Hypogammaglobulinemia, Chron...

Intravenous Immunoglobulin Market Report 2026 - Global Outlook – By Type (IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)), By Distribution Channel (...

Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market Report 2026 - Global Outlook – By Product (Cardiac Markers, Metabolic Markers, Renal Markers, Other Products), By Source Animal (Goat, Rabbit, Horse, Mouse, Oth...

Hyperimmune Globulins Market Report 2026 - Global Outlook – By Type (Hepatitis B Hyperimmune Globulin, Rabies Hyperimmune Globulin, Tetanus Hyperimmune Globulin, Cytomegalovirus (CMV) Hyperimmune Globulin, Varicella-Zost...

Immunohematology Market Report 2026 - Global Outlook – By Product (Analyzers And Systems, Reagents), By Technology (Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PC...

Immunoassay Market Report 2026 - Global Outlook – By Product (Reagents And Kits, Analyzers Or Instruments, Software And Services), By Specimen (Blood, Saliva, Urine, Other Specimens), By Application (Therapeutic Drug Mon...

Immunodiagnostics Market Report 2026 - Global Outlook – By Product (Reagents And Consumables, Instruments), By Technology (Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Rapid ...

Frequently Asked Questions

How big is the Subcutaneous Immunoglobulin (SCIG) Market?

The Subcutaneous Immunoglobulin (SCIG) market was valued at $14.39 billion in 2025, increased to $16.32 billion in 2026, and is projected to reach $25.71 billion by 2030. request a sample here

What is the Subcutaneous Immunoglobulin (SCIG) market growth?

The global Subcutaneous Immunoglobulin (SCIG) market is expected to grow at a CAGR of 12.0% from 2026 to 2035 to reach $25.71 billion by 2035. request a sample here

Who are the key players in Subcutaneous Immunoglobulin (SCIG) market?

Some Key Players in the Subcutaneous Immunoglobulin (SCIG) market Include, CSL Behring, Grifols S.A., Octapharma AG, Kedrion Biopharma, LFB Group, Biotest AG, Bio Products Laboratory Ltd., ADMA Biologics Inc., Kamada Pharmaceuticals, Takeda Pharmaceutical Company Limited, Baxter International Inc., Bharat Serums and Vaccines Limited, Emergent BioSolutions Inc., Pfizer Inc., Johnson & Johnson, Lonza Group, Argenx SE, CinnaGen Co., Intas Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd. . request a sample here

What is the anticipated growth trend for the Subcutaneous Immunoglobulin (SCIG) market?

Major trend in this market includes: Advancements In Subcutaneous Immunoglobulin (SCIG) Technology Improve Treatment Convenience And Patient Self-Management. For further insights on this market. request a sample here

Which region has the most growth potential in the Subcutaneous Immunoglobulin (SCIG) market?

North America was the largest region in the subcutaneous immunoglobulin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the subcutaneous immunoglobulin (scig) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Subcutaneous Immunoglobulin (SCIG) Market Report 2026 market?

Major companies operating in the Subcutaneous Immunoglobulin (SCIG) Market Report 2026 market are Major companies operating in the subcutaneous immunoglobulin (scig) market are CSL Behring, Grifols S.A., Octapharma AG, Kedrion Biopharma, LFB Group, Bio request a sample here.